3D Medicines Inc. (01244.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 2.33

From 52W high−73.89%

Volume44000.00

Market capHKD 606.36M

P/E (TTM)—

P/S (TTM)1.4x

Div yield—

Key dataSep 18, 2026

Open

HKD 2.33

From 52W high

−73.89%

Volume

44000.00

Market cap

HKD 606.36M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.4x

P/E (TTM)

—

RSI (14)

51.9

MomentumView details →

1D Return

+9.29%

YTD Return

−53.66%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.4x

EV/Sales

0.7x

P/S (TTM)

1.4x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

88.53%

Net Margin

−48.51%

EBITDA Margin

−47.87%

ROE (TTM)

−33.06%

ROA (TTM)

−18.51%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

−20.23%

EPS YoY

−4.41%

FCF YoY

—

Revenue CAGR 3Y

−14.38%

EPS CAGR 3Y

+4.00%

EBITDA YoY

+14.36%

MomentumView details →

1D Return

+9.29%

YTD Return

−53.66%

1Y Return

−69.51%

RSI (14)

51.9

vs 50D SMA

+5.55%

vs 200D SMA

−31.23%

Capital & dividendView details →

Debt/Equity

0.33x

Current Ratio

1.21x

Quick Ratio

1.20x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

806.07M

Net Income (TTM)

−342.01M

Op. CF (TTM)

−167.23M

Latest newsMore news →

On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.32d ago

3D Medicines announced that the arbitration award in its favor against SELLAS Life Sciences Group has been fully executed, with SELLAS ordered to pay approximately 7.983 million yuan in costs, which has been received in full.34d ago

Similar companies

Phathom Pharmaceuticals, Inc.PHAT Shattuck Labs, Inc.STTK CorMedix Inc.CRMD CytomX Therapeutics, Inc.CTMX AgomAb Therapeutics N.V. American Depositary SharesAGMB Bright Minds Biosciences Inc.DRUG Find similar companies →

Latest newsMore news →

On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.32d ago 3D Medicines announced that the arbitration award in its favor against SELLAS Life Sciences Group has been fully executed, with SELLAS ordered to pay approximately 7.983 million yuan in costs, which has been received in full.34d ago